|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This site is dedicated to Cindi McCain & Lou Grubb: Friends & Stroke Survivors....(ALLOW 1 MINUTE TO LOAD)....We search 100's of internet sites for daily news: New York Times, Washington Post, LA Times, Chicago Tribune, Harvard, Yale, UCLA, CNN, FOX, CBS, NBC, ABC, BBC, Journal of American Medical Assoc., New England Journal of Medicine, Mayo Clinic, Johns Hopkins Medicine, Cleveland Clinic, Memorial Sloan- Kettering, Reuters & 100's more...(WE DO NOT ACCEPT ADVERTISING) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Tuesday
Inflammatory-Enzyme Shown to Predict Risk of Cardiovascular Events After Acute Coronary Syndromes:
"New results from a majorcardiovascular study showed that when measured approximately 30 days after an acute coronary event such as chest pain or heart attack, elevated levels of Lp-PLA2 (lipoprotein-associated phospholipase A2) activity are an independent risk marker for death or recurrent cardiovascular (CV) events.(1) Lp-PLA2 activity has been associated with the development and progression of atherosclerosis, a process that may lead to heart attack, stroke or other serious CV events but until now, little information has been available on theprognostic role of Lp-PLA2 in patients following acute coronary syndromes (ACS). Results from this substudy of the PRavastatin Or atorVastatin Evaluation and Infection Therapy (PROVE IT-TIMI 22) trial were published today in the American Heart Association's journal Circulation." |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||